DNA targeting mononuclear Ni(II) and Cu(II) metallocarboxylates of 2,3,4,9-tetrahydro-β-carboline-3-carboxylic acid: a combined in silico to in vitro approach with antibacterial and anticancer assays against MDA-MB-231 cell lines
Abstract
β -carboline alkaloid-based ligand, 2,3,4,9-tetrahydro- β -carboline-3-carboxylic acid (NZ1), a recognized active metabolite in plants, animals, and humans, was synthesized and subsequently complexed with Ni(II) and Cu(II) ions to yield the new mononuclear metallocarboxylate complexes NZ2 and NZ3 respectively. The structural characterization confirmed the successful coordination of the central metal atom to the ligand framework. The non-covalent interactions of these compounds with the chicken blood ds-DNA were investigated through UV–visible absorption, fluorescence emission spectroscopy, viscosity measurements and molecular docking studies. Photophysical changes observed under UV-Visible and Fluorescence spectroscopic studies clearly predicted the presence of dominant minor groove binding as all compounds exhibited hyperchomic effect without any remarkable shift in UV absorption maxima and progressive quenching of intrinsic fluorescence intensities upon addition of ds-DNA without notable shifts in emission maxima. While viscometric measurements and molecular docking studies for all compounds confirmed dominant minor groove binding interaction rather than classical intercalation. Notably, NZ3 demonstrated the highest DNA affinity as followed by NZ2 and NZ1. In antioxidant assays, metal complexation significantly enhanced the free-radical scavenging activity and NZ3 complex demonstrated superior efficacy. The anticancer potential against triple-negative breast cancer cell…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.